TheProfitWatch

HUMA - Humacyte, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.8 -0.01 (-0.62%) --- 0.0 (0.0%) 0.01 (0.5%) 0.0 (0.0%) -0.04 (-2.22%) 0.02 (1.07%) 0.02 (1.07%)

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.24
Diluted EPS:
-0.24
Basic P/E:
-7.4538
Diluted P/E:
-7.4538
RSI(14) 1m:
0.0
VWAP:
1.79
RVol:

Events

Period Kind Movement Occurred At

Related News